PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 54 filers reported holding PRINCIPIA BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $155,000 | +64.9% | 2,598 | +64.3% | 0.01% | +40.0% |
| Q1 2020 | $94,000 | +8.0% | 1,581 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $87,000 | +163.6% | 1,581 | +36.1% | 0.00% | +100.0% |
| Q3 2019 | $33,000 | -15.4% | 1,162 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $39,000 | +143.8% | 1,162 | +144.6% | 0.00% | +100.0% |
| Q1 2019 | $16,000 | +23.1% | 475 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $13,000 | – | 475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 914,625 | $50,103,000 | 10.88% |
| Samsara BioCapital, LLC | 306,784 | $16,806,000 | 8.05% |
| BVF INC/IL | 1,716,734 | $94,043,000 | 7.13% |
| Sofinnova Investments, Inc. | 1,417,258 | $77,637,000 | 5.60% |
| Cormorant Asset Management, LP | 1,990,922 | $109,063,000 | 4.35% |
| Redmile Group, LLC | 2,722,388 | $149,132,000 | 3.57% |
| Endurant Capital Management LP | 66,157 | $3,624,000 | 1.14% |
| EAM Global Investors LLC | 37,904 | $2,076,000 | 0.83% |
| EAM Investors, LLC | 58,247 | $3,191,000 | 0.70% |
| Baker Brothers Advisors | 1,787,957 | $97,944,000 | 0.52% |